ArticleBMC musculoskeletal disorders2017

Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy.

Tero Puolakkainen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.